Niche science: The aging stem cell

Studies on stem cell aging are uncovering molecular mechanisms of regenerative decline, providing new insight into potential rejuvenating therapies.Studies on stem cell aging are uncovering molecular mechanisms of regenerative decline, providing new insight into potential rejuvenating therapies. Most human tissues retain an amazing ability to regenerate well into adulthood. Somatic stem cells are central to this ability, replacing damaged cells and thus keeping the body in a highly functional state. Yet this process does not continue unabated forever, as aging is accompanied by a loss of this regenerative capacity. Presently, studies in invertebrate and vertebrate model systems are advancing our understanding of regenerative decline and are identifying strategies for ‘rejuvenating’ therapies that have the potential to extend human health- and lifespan.The feasibility of rejuvenating interventions was demonstrated by classic studies in which exposure to a young systemic environment restored regenerative capacity of muscle stem cells in old mice.¹ Similar rejuvenation has now been demonstrated for the central nervous system, suggesting that such interventions have systemic potential² and raising the question of whether the lifespan of the organism could be extended by restoring the regenerative capacity of adult stem cells. This has already been demonstrated in flies, where improved intestinal stem cell function leads to enhanced longevity.³Such studies have inspired the burgeoning field of “stem cell aging.”^4,5 A recent symposium at the Buck Institute for Research on Aging in Novato, CA showcased the field, bringing together researchers interested in the biology of aging and experts in stem cell biology, and covering topics ranging from basic research in stem cell aging to the use of stem cells in clinical applications. Clear from the meeting is that new molecular insight into stem cell aging is emerging at a rapid pace, revealing both the promises and challenges of deploying stem cell therapies for age-related diseases. The key questions are starting to be answered.